Uses of ANCOLASE - 250
A glycopeptide, active against Gram positive organisms including methicillin resistant Staphylococcus aureus. It is the standard answer when a resistant Gram positive organism is confirmed or strongly suspected.
Vancomycin in particular is a drug whose dosing is followed closely: it is cleared renally, its effect tracks exposure rather than peak concentration, and therapeutic drug monitoring is routine in serious infection. Distributors supplying ICUs are usually supplying it continuously.
- Confirmed or suspected MRSA infection
- Serious Gram positive infection in patients with beta lactam allergy
- Catheter related bloodstream infection
- Endocarditis, bone and joint infection, as directed
- Febrile neutropenia, as part of a combination regimen
Indication categories, not an exhaustive list, and not a recommendation for any individual patient.
Quality-driven manufacturing behind ANCOLASE - 250
Why Monark Criticare versus a typical supplier?
Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.
Start your critical care business with ANCOLASE - 250 — take the district before it is allocated
Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.
Get franchise quoteGet franchise quote for ANCOLASE - 250
Interested in Vancomycin-250 for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.
- ✓Exclusive district rights, recorded in the agreement
- ✓Net rates, pack sizes and MRP issued before you commit
- ✓No minimum on the first two order cycles
- ✓Batch documentation and certificate of analysis with every consignment
Send enquiry
Fill in your details and we will contact you shortly.
